AG真人官方

MetLife, Inc. (MET) 鈥� Form 144 filing: The notice discloses a proposed sale of 101 common shares with an aggregate market value of $7,933.55. The shares were originally purchased on 12/17/2019 for cash and are slated to be sold through Barclays Capital on or about 06/20/2025 on the NYSE. The issuer has 671,297,826 shares outstanding, so the planned transaction represents less than 0.00002 % of equity. The filing also lists earlier sales by related MetLife accounts over the past three months totaling 686 shares for gross proceeds of $55,391.75. The signer affirms no undisclosed material adverse information and Rule 144 compliance.

MetLife Director Robert Glenn Hubbard acquired 964 shares of common stock on June 17, 2025, at a price of $77.85 per share, bringing his total direct beneficial ownership to 100,489 shares.

The acquisition was part of MetLife's non-management director compensation arrangements, where a portion of director retainer fees is paid in company common stock. Hubbard elected to defer the receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Key transaction details:

• Transaction type: Acquisition of non-derivative securities
• Total value of transaction: Approximately $75,047 (964 shares 脳 $77.85)
• Ownership form: Direct
• Filing made as an individual reporting person

MetLife Director Jeh C. Johnson reported the acquisition of 562 shares of common stock at $77.85 per share on June 17, 2025, bringing total direct ownership to 6,789 shares.

The transaction was part of MetLife's non-management director compensation arrangement, where a portion of director retainer fees is paid in company stock. Johnson elected to defer the receipt of these shares through the MetLife Deferred Compensation Plan for Non-Management Directors.

• Transaction Type: Acquisition (Code A)
• Form Type: Form 4 (Statement of Changes in Beneficial Ownership)
• Transaction Value: Approximately $43,752
• Ownership: Direct

This routine compensation-related transaction demonstrates continued alignment between director and shareholder interests through equity-based compensation.

MetLife director Denise M. Morrison reported the acquisition of 562 shares of common stock on June 17, 2025 as part of the company's non-management director compensation arrangements. The shares were acquired at $0 cost as part of director retainer fees paid in company stock.

Following this transaction, Morrison now beneficially owns a total of 32,817 shares directly. The filing indicates this is a routine compensation-related acquisition for board service rather than an open market purchase.

• Transaction Type: Stock Award (Compensation)
• Form of Ownership: Direct
• Role: Non-Management Director
• No derivative securities were involved in this transaction

MetLife director Christian Stephane Mumenthaler acquired 562 shares of common stock on June 17, 2025 at a price of $77.85 per share, bringing total direct ownership to 918 shares.

The transaction was part of MetLife's non-management director compensation arrangement, where a portion of director retainer fees is paid in company stock. Notably, Mumenthaler elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

• Transaction Type: Acquisition (Form 4)
• Total Transaction Value: $43,751.70
• Ownership Type: Direct
• Role: Non-Management Director

Form 4 overview 鈥� MetLife, Inc. (MET)

Director Mark A. Weinberger reported a routine equity award on 17 Jun 2025. He received 562 shares of MetLife common stock at a stated price of $0, reflecting the company鈥檚 practice of paying a portion of non-management director retainers in shares. Following the transaction, Weinberger鈥檚 direct ownership increased to 16,907 shares.

No derivative securities were involved and the filing contains no additional purchases, sales or option exercises. The award appears to be automatic, formula-based compensation and does not signal discretionary buying or selling by the director.

MetLife, Inc. (NYSE: MET) 鈥� Form 4 insider transaction filed 20 Jun 2025

Non-management director Diana McKenzie reported the acquisition of 562 shares of MetLife common stock on 17 Jun 2025 at a reference price of $77.85 per share. The transaction was coded 鈥淎(1),鈥� indicating the shares were issued as part of the company鈥檚 non-management director compensation plan rather than an open-market purchase. After the grant, McKenzie鈥檚 direct beneficial ownership rose to 22,065 shares.

The filing notes that the director elected to defer receipt of the shares under the MetLife Deferred Compensation Plan for Non-Management Directors. No derivative securities were reported, and there were no dispositions.

While the amount is immaterial relative to MetLife鈥檚 ~805 million shares outstanding, routine equity compensation aligns director incentives with shareholder returns and remains a data point for governance and insider-sentiment trackers.

MetLife, Inc. (MET) 鈥� Form 4 insider transaction filed 20 June 2025

Independent director William E. Kennard reported an automatic acquisition of 562 common shares on 17 June 2025. The shares were credited at a reference price of $77.85 under the company鈥檚 non-management director compensation program and immediately deferred into the MetLife Deferred Compensation Plan for Non-Management Directors. No open-market cash outlay occurred.

Following the transaction, Kennard鈥檚 direct ownership stands at 43,606 common shares. He also retains 10 shares indirectly through the MetLife Policyholder Trust, bringing his total reported beneficial holding to 43,616 shares.

The filing carries code 鈥淎(1),鈥� indicating an exempt award related to board fees rather than discretionary buying or selling. No derivative securities were involved, and there were no dispositions. The update is routine, modest in size (<0.001 % of shares outstanding), and does not affect MetLife鈥檚 capital structure or liquidity.

Key takeaways for investors

• Incremental increase in insider equity aligns director incentives with shareholders.
• Because the shares were part of standard board compensation, the filing does not signal strategic sentiment or anticipated operational developments.
• Beneficial ownership data remains well below any control threshold; governance dynamics unchanged.

MetLife, Inc. (MET) filed a Form 4 reporting routine insider activity by non-management director Carlos M. Gutierrez. On 06/17/2025, Gutierrez received 562 shares of common stock (transaction code A) at a stated price of $0, reflecting the company鈥檚 policy to pay a portion of director retainers in equity. Following the grant, the director now owns 23,851 shares directly and 18,807 shares indirectly through the Carlos M. Gutierrez Trust. No derivative securities were involved, and the filing contains no sales or dispositions.